Skip to main content
. 2020 May 8;13:1756284820913210. doi: 10.1177/1756284820913210

Table 2.

Patient response to questionnaire.

Demographic and clinical characteristics Overall
n 52
Age [mean (SD)] 59.02 (13.43)
Sex (male) (%) 21 (40.4)
Disease activity according to PGA (%)
remission 25 (48.1)
active disease 24 (46.2)
Moderate disease activity 3 (5.8)
Abdominal pain, frequency (%)
1 Less than once a week 18 (34.6)
2 1–2 times a week 9 (17.3)
3 3–6 times per week 7 (13.5)
4 Daily 18 (34.6)
Abdominal pain, duration (%)
1 <30 min 17 (32.7)
2 0.5 h to 1 h 7 (13.5)
3 1–6 h 6 (11.5)
4 >6 h 22 (42.3)
Abdominal pain, severity (%)
0 No pain 12 (23.1)
1 Mild pain 8 (15.4)
2 Moderate pain 7 (13.5)
3 Severe pain 4 (7.7)
4 Very severe pain 21 (40.4)
Number of additional symptoms (%) (choose any of the following: bloating, tenesmus, change in bowel habits)
0 11 (21.2)
1 18 (34.6)
2 6 (11.5)
3 17 (32.6)
Missed activities during last 2 weeks (%) 24 (46.2)
Woken up at night during last 2 weeks (%) 23 (44.2)
Experienced lack of energy in last 2 weeks (%) 32 (61.5)
Felt anxious or depressed in last 2 weeks (%) 24 (46.2)
Felt the need to change treatment in last 2 weeks (%) 23 (44.2)

PGA, physician global assessment; SD, standard deviation.